Subscribe To
Viracta therapeutics to present at the stifel 2023 targeted oncology days
SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and pr...
April 19, 2023, 8:30 pm
7 biotech stocks that could cure your portfolio woes
Fundamentally, the driving catalyst for biotech stocks to buy centers on the possibility of supporting paradigm-shifting medical breakthroughs. For ex...
April 19, 2023, 7:22 pm
Emulate therapeutics inc. (emtx) announces company presentation at life sciences innovation north-west 2023
Low to ultra-low radio frequency energy signals (ulRFE®) are the basis of the new digital therapeutic innovation by EMTx BELLEVUE, Wash., April 18, 2...
April 19, 2023, 2:31 am
Medical imaging equipment market to cross usd 50.3 bn revenue by 2028 with cagr of 5.4%, says transparency market research
The global market for medical imaging equipment is being driven by an increasing demand in the healthcare sector, caused by a rise in the prevalence o...
April 18, 2023, 9:30 pm
Quanta therapeutics presents data from kras inhibitor pipeline at annual aacr meeting in late-breaking research session
– Data highlight favorable preclinical profiles for two chemically-distinct allosteric, oral small molecule KRAS inhibitors with potent anti-tumor a...
April 14, 2023, 4:05 pm
Aadi bioscience to present multiple posters on nab-sirolimus at the 2023 american association for cancer research (aacr) annual meeting
LOS ANGELES , April 14, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing ...
April 14, 2023, 1:09 pm
Cti biopharma to participate in two upcoming investor conferences in april 2023
SEATTLE, Wash. , April 12, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development ...
April 12, 2023, 4:30 pm
Merck (mrk) keytruda studies in difficult-to-treat cancers fail
Merck (MRK) and Eisai announce the discontinuation of the phase III LEAP-003 study seeking approval of the Keytruda and Lenvima combo. Another phase I...
April 10, 2023, 9:54 am
Aadi bioscience to present multiple posters at the american association for cancer research (aacr) annual meeting 2023
LOS ANGELES , April 6, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing a...
April 6, 2023, 4:35 pm
Revolution medicines to present preclinical data at the upcoming american association for cancer research annual meeting 2023
REDWOOD CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targe...
April 6, 2023, 7:00 am
Rapt therapeutics: potential strong upside ahead
RAPT Therapeutics, Inc. is a clinical-stage biotech developer of specific small molecules that can modulate the critical immune drivers of inflammator...
March 30, 2023, 12:12 am
Cns pharmaceuticals to present at the virtual investor gbm spotlight event
Live moderated video webcast with members of CNS Pharmacetucals management and Key Opinion Leader, Professor Michael Weller, MD, on Tuesday, April 4 t...
March 29, 2023, 9:05 am
Roche's slow growth shouldn't drive investors away
The decline in sales of COVID-19 products hurt the company's 2022 bottom line. Many new treatments for cancers...
March 28, 2023, 6:20 am
Aim immunotech to report full year 2022 financial results on march 31, 2023 and host inaugural quarterly conference call and webcast
OCALA, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company fo...
March 27, 2023, 9:05 am
Biontech inks deal with oncoc4 to develop cancer treatments
BioNTech SE BNTX, -1.76% will pay $200 million to the privately held OncoC4 Inc. as part of a deal to develop and commercialize OncoC4's monoclonal an...
March 20, 2023, 8:35 am
Qualigen therapeutics to present five posters at the american association for cancer research annual meeting 2023
CARLSBAD, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified li...
March 15, 2023, 9:05 am
Mersana therapeutics provides statement about svb
CAMBRIDGE, Mass., March 10, 2023 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on...
March 11, 2023, 12:10 am
Imv inc. to announce fourth quarter and fiscal year 2022 results and host a conference call and webcast on march 16, 2023
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #CancerVaccine--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company develop...
March 9, 2023, 7:05 am
Viracta therapeutics to present at the 33rd annual oppenheimer healthcare conference
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and pre...
March 8, 2023, 4:05 pm
Revolution medicines announces pricing of $300.0 million public offering of common stock
REWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targe...
March 3, 2023, 2:15 am